All companies
Visit website
MOONSTONE NUTRITION
OperatingMoonstone Nutrition Inc.
Healthcare · Founded 2019
OTC remedy, designed to prevent kidney stones
Post-money valuation ⓘ
$30.3M
As of Sep 2024 · from Moonstone Nutrition Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$290,725
Across 1 round since 2024
Latest share price
$3.06
Moonstone Nutrition Common Stock 1 offering price
Financials
FY2022–FY2025 · from SEC filings · hover any figure for its source$1.1M
−$1.1M
2022
$1.9M
−$867K
2023
$1.9M
−$727K
2024
$2.5M
−$9K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$1,059,816
$1,930,901
$1,934,497
$2,536,145
Cost of goods sold
$594,547
$1,148,114
$1,232,154
$1,327,124
Gross margin
44%
41%
36%
48%
Net income
-$1,135,599
-$866,918
-$727,358
-$8,730
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$139,442
$114,954
$92,239
$395,692
Accounts receivable
$32,582
$78,709
$77,102
$65,552
Total assets
$474,702
$814,067
$518,930
$809,591
Short-term debt
$700,045
$59,448
$339,448
$339,448
Long-term debt
$277,613
$284,838
$292,063
$299,288
Total liabilities
$977,658
$344,286
$631,511
$638,736
Other
Headcount
—
3
3
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$30.3M
post-money
Moonstone Nutrition Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $290.7K / $1.2MInvestors 184Post-money $30.3M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 2 annual reports (FY2024–FY2025)
184 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002014005Share price $3.06
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.